Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants	$ 0	$ 438,000
Revolving credit borrowings	850,000	1,950,000
Proceeds from Issuance or Sale of Equity	$ 3,056,981	0
Document Period End Date	Jun. 30, 2018
Cash flows from operating activities:
Net loss	$ (4,425,652)	(4,602,549)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	156,593	436,781
Amortization of Other Deferred Charges	173,676	0
Stock compensation expense	18,101	34,585
Change in assets and liabilities:
Accounts receivable, net	31,607	1,234,503
Inventories	1,038,770	191,202
Prepaid expenses and other current assets	243,025	82,545
Other assets	24,576	(18,209)
Accounts payable	(1,079,272)	350,578
Accrued compensation and employee benefits	78,530	178,871
Accrued expenses	(100,893)	(85,454)
Unearned revenue	106,883	44,284
Other liabilities	10,721	63,235
Net cash provided by (used in)	(3,723,335)	(2,089,628)
Cash flows from investing activities:
Increase (Decrease) in Trading Securities	(293)	(340)
Payments to Acquire Property, Plant, and Equipment	(41,118)	(130,971)
Net Cash Provided by (Used in) Investing Activities	(41,411)	(131,311)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Net Cash Provided by (Used in) Financing Activities	3,906,981	1,950,000
Effect of Exchange Rate on Cash and Cash Equivalents	(22,062)	315,483
Cash and Cash Equivalents, Period Increase (Decrease)	120,173	44,544
Cash at beginning of year	2,253,952	$ 1,954,422
Cash at end of period	$ 2,374,125